alexa Reprogrammed Cells: How Far Away from the Clinical Use

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Reprogrammed Cells: How Far Away from the Clinical Use

Currently, the  discovery  of Compounds induced Pluripotent Stem Cells (CiPSCs) and the  Stimulus-Triggered  Acquisition  of Pluripotency (STAP) cells are rocking the field of stem cells. In 1981, the first embryonic stem cells (ESCs) were first derived from mouse embryos by two groups respectively. In 1998, a breakthrough occurred when Thomson group first developed a technique to isolate and grow human ESCs in cell culture. The finding of ESCs, especially the human ESCs, brought the hope for the regeneration medicine. However, because of the ethic issues and potential xenograft rejection problems of human ESCs, it is very hard for the derivatives of human ESCs to go directly towards clinical application.



Image result for 6 well cell culture plate

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger